- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有10家主力机构披露2025-06-30报告期持股数据，持仓量总计234.94万股，占流通A股7.14%
- 波段诊断：
-
技术面诊股
诊断结果：6.3技术面打败了56%的股票
技术面评分前10的股票
近期的平均成本为26.37元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为26.37元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"26.37","date":1767083620,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑赢行业平均水平。
[{"date":"2025.12.31","stock":"0.23","trade":"-0.42","ind":"-0.58"},{"date":"2025.12.30","stock":"-0.94","trade":"-0.80","ind":"0.49"},{"date":"2025.12.29","stock":"-0.34","trade":"-1.56","ind":"-0.49"},{"date":"2025.12.26","stock":"-0.82","trade":"-0.59","ind":"0.54"},{"date":"2025.12.25","stock":"0.48","trade":"0.49","ind":"0.33"},{"date":"2025.12.24","stock":"1.09","trade":"0.14","ind":"0.88"},{"date":"2025.12.23","stock":"-0.60","trade":"-1.13","ind":"0.27"},{"date":"2025.12.22","stock":"-0.74","trade":"-0.02","ind":"1.47"},{"date":"2025.12.19","stock":"0.04","trade":"1.30","ind":"0.66"},{"date":"2025.12.18","stock":"1.93","trade":"0.74","ind":"-1.29"},{"date":"2025.12.17","stock":"0.38","trade":"0.75","ind":"2.40"},{"date":"2025.12.16","stock":"-2.16","trade":"-1.92","ind":"-1.51"},{"date":"2025.12.15","stock":"-1.25","trade":"-0.38","ind":"-1.10"},{"date":"2025.12.12","stock":"1.15","trade":"-0.79","ind":"0.84"},{"date":"2025.12.11","stock":"-1.50","trade":"-1.22","ind":"-1.27"},{"date":"2025.12.10","stock":"-1.87","trade":"-0.11","ind":"0.29"},{"date":"2025.12.09","stock":"-3.37","trade":"-1.56","ind":"-0.39"},{"date":"2025.12.08","stock":"0.03","trade":"-0.39","ind":"1.39"},{"date":"2025.12.05","stock":"-0.14","trade":"-0.36","ind":"1.08"},{"date":"2025.12.04","stock":"-1.67","trade":"-1.07","ind":"0.40"},{"date":"2025.12.03","stock":"-0.34","trade":"1.34","ind":"-0.78"}]
恩威医药,深证成指,中药指数
压力支撑
该股压力位为26.38元，支撑位为26.19元。
[{"text":"\u538b\u529b\u4f4d","value":"26.38","date":1767110400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"26.19","date":1767110400,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：6.2资金面打败了86%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：01月02日 20:31
| 机构今日流向(万元) | -765.10 | 机构5日流向(万元) | -3138.61 |
| 机构10日流向(万元) | -4676.73 | 机构20日流向(万元) | -18586.55 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少216.47万股，其中基金净增仓1家，主力净减仓12家，暂未发现中长期投资价值。
截止2025-06-30，共10家主力机构（基金6家，QFII3家，一般法人1家），持仓量总计234.94万股，占流通A股7.14%
其中，基金持仓与2024-12-31相比：
增仓：1家 ，增持 42.94万股
减仓：0家 ，减持 0万股
新出现在主力名单中：8家 ，持有130.41万股
从主力名单中消失：20家 ，原持有342.9万股
其中，基金持仓与2024-12-31相比：
增仓：1家 ，增持 42.94万股
减仓：0家 ，减持 0万股
新出现在主力名单中：8家 ，持有130.41万股
从主力名单中消失：20家 ，原持有342.9万股
消息面诊股
诊断结果：6.9消息面打败了97%的股票
今日有利好新闻的公司
近期该股利好消息较多，投资者可加强关注。
更多>>个股资讯
- 恩威医药：12月30日获融资买入290.27万元
2025-12-31 - 恩威医药2025年前三季度每10股派3.5元 股
2025-12-30 - 恩威医药：以1.02亿股为基数向全体股东每10股派
2025-12-30 - 恩威医药：12月29日获融资买入187.97万元
2025-12-30 - 恩威医药：12月26日获融资买入563.51万元
2025-12-29 - 恩威医药：每10股派发现金红利3.5元
2025-12-26 - 恩威医药：12月25日获融资买入299.83万元
2025-12-26 - 恩威医药：12月24日获融资买入117.56万元
2025-12-25 - 恩威医药：海南定安恩威实业有限公司与公司已不存在任
2025-12-24 - 恩威医药：12月22日获融资买入204.86万元
2025-12-23
消息列表
| 利好 | 分红转增 | 10派3.5元(含税) | 2025-12-26 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-11-26 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-11-20 |
| 一般消息 | 募资投向 | 2025-09-19 | |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-08-27 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-26 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-06-23 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-06-03 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-17 |
| 一般消息 | 高管变动 | 修订章程取消监事会 | 2025-05-12 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-21 |
| 利好 | 分红转增 | 10派1.8元(含税) | 2025-04-21 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-21 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2025-01-17 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：2.1行业面打败了14%的股票
中药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2025.12.31","price":"-0.58","value":"-0.42"},{"date":"2025.12.30","price":"0.49","value":"-0.80"},{"date":"2025.12.29","price":"-0.49","value":"-1.56"},{"date":"2025.12.26","price":"0.54","value":"-0.59"},{"date":"2025.12.25","price":"0.33","value":"0.49"},{"date":"2025.12.24","price":"0.88","value":"0.14"},{"date":"2025.12.23","price":"0.27","value":"-1.13"},{"date":"2025.12.22","price":"1.47","value":"-0.02"},{"date":"2025.12.19","price":"0.66","value":"1.30"},{"date":"2025.12.18","price":"-1.29","value":"0.74"},{"date":"2025.12.17","price":"2.40","value":"0.75"},{"date":"2025.12.16","price":"-1.51","value":"-1.92"},{"date":"2025.12.15","price":"-1.10","value":"-0.38"},{"date":"2025.12.12","price":"0.84","value":"-0.79"},{"date":"2025.12.11","price":"-1.27","value":"-1.22"},{"date":"2025.12.10","price":"0.29","value":"-0.11"},{"date":"2025.12.09","price":"-0.39","value":"-1.56"},{"date":"2025.12.08","price":"1.39","value":"-0.39"},{"date":"2025.12.05","price":"1.08","value":"-0.36"},{"date":"2025.12.04","price":"0.40","value":"-1.07"},{"date":"2025.12.03","price":"-0.78","value":"1.34"}]
深证成指,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 万邦德 | 8.91% | 14.18% | 6.6分 |
| 2 | 维康药业 | 2.45% | 1.76% | 5.4分 |
| 3 | 东阿阿胶 | 2.40% | 0.02% | 6.2分 |
| 4 | 天目药业 | 2.37% | 0.82% | 5.8分 |
| 5 | 云南白药 | 1.88% | 0.46% | 6.4分 |
| 6 | 吉林敖东 | 1.72% | -0.51% | 5.2分 |
| 8 | 华润三九 | -0.59% | -0.70% | 5.9分 |
| 10 | 方盛制药 | -1.23% | -1.75% | 5.2分 |
| 12 | 达仁堂 | -1.49% | -2.19% | 5.4分 |
| 14 | 马应龙 | -2.27% | -2.41% | 4.6分 |
| 16 | 古汉医药 | -3.03% | 0.72% | 5.7分 |
| 18 | 同仁堂 | -3.85% | 1.54% | 5.4分 |
| 20 | ST香雪 | -4.21% | -4.31% | 5.1分 |
| 22 | - | -4.53% | -2.89% | 分 |
| 24 | 济川药业 | -4.71% | -0.53% | 5.2分 |
| 26 | 九芝堂 | -5.11% | -2.46% | 5.3分 |
| 28 | 奇正藏药 | -5.28% | -1.83% | 5.3分 |
| 30 | 亚宝药业 | -5.39% | -2.26% | 5.2分 |
| 32 | 三力制药 | -5.65% | -1.18% | 5.5分 |
| 34 | 康恩贝 | -5.91% | -1.76% | 4.9分 |
| 36 | 千金药业 | -6.36% | -1.55% | 4.9分 |
| 38 | 康缘药业 | -6.74% | -1.33% | 4.8分 |
| 40 | 新天药业 | -6.85% | -1.39% | 5.4分 |
| 42 | 羚锐制药 | -7.05% | -1.47% | 5.5分 |
| 44 | 步长制药 | -7.89% | -5.21% | 5.1分 |
| 46 | 桂林三金 | -8.14% | -3.56% | 4.9分 |
| 48 | 中恒集团 | -8.97% | -2.84% | 4.4分 |
| 50 | 以岭药业 | -9.25% | -1.39% | 5.0分 |
| 52 | 健民集团 | -9.90% | -5.25% | 4.7分 |
| 54 | 精华制药 | -11.46% | -1.49% | 5.2分 |
| 56 | 华神科技 | -11.64% | -2.27% | 5.1分 |
| 58 | 太龙药业 | -12.15% | -4.08% | 4.6分 |
| 60 | 新光药业 | -15.15% | -2.93% | 4.5分 |
| 62 | 盘龙药业 | -16.22% | -2.99% | 4.8分 |
| 64 | 信邦制药 | -17.44% | -2.42% | 4.8分 |
| 66 | ST百灵 | -22.60% | -14.37% | 4.3分 |
| 68 | 粤万年青 | -32.04% | -4.37% | 4.2分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 42/109 ， 42/109。
[{"date":"2025-09-30","value":"3.42","vol":"4.74"},{"date":"2025-06-30","value":"3.58","vol":"3.98"},{"date":"2025-03-31","value":"1.53","vol":"2.21"},{"date":"2024-12-31","value":"3.47","vol":"4.80"},{"date":"2024-09-30","value":"2.07","vol":"2.91"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
3.42 | 3.58 | 1.53 | 3.47 | 2.07 |
| 行业(%) | 4.74 | 3.98 | 2.21 | 4.80 | 2.91 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"48.22","vol":"52.31"},{"date":"2025-06-30","value":"49.10","vol":"52.86"},{"date":"2025-03-31","value":"48.13","vol":"53.38"},{"date":"2024-12-31","value":"50.82","vol":"52.74"},{"date":"2024-09-30","value":"50.95","vol":"53.11"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
48.22 | 49.10 | 48.13 | 50.82 | 50.95 |
| 行业(%) | 52.31 | 52.86 | 53.38 | 52.74 | 53.11 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 5/109 ， 13/109。
[{"date":"2025-09-30","value":"13.65","vol":"-7.31"},{"date":"2025-06-30","value":"15.73","vol":"-7.31"},{"date":"2025-03-31","value":"7.10","vol":"-7.18"},{"date":"2024-12-31","value":"3.43","vol":"-7.35"},{"date":"2024-09-30","value":"-1.67","vol":"-5.11"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
13.65 | 15.73 | 7.10 | 3.43 | -1.67 |
| 行业(%) | -7.31 | -7.31 | -7.18 | -7.35 | -5.11 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"66.13","vol":"-2.54"},{"date":"2025-06-30","value":"113.80","vol":"2.98"},{"date":"2025-03-31","value":"93.56","vol":"-37.19"},{"date":"2024-12-31","value":"-56.56","vol":"-146.29"},{"date":"2024-09-30","value":"-69.81","vol":"61.78"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
66.13 | 113.80 | 93.56 | -56.56 | -69.81 |
| 行业(%) | -2.54 | 2.98 | -37.19 | -146.29 | 61.78 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 23/109 ， 12/109。
[{"date":"2025-09-30","value":"0.42","vol":"0.35"},{"date":"2025-06-30","value":"0.30","vol":"0.24"},{"date":"2025-03-31","value":"0.13","vol":"0.12"},{"date":"2024-12-31","value":"0.57","vol":"0.50"},{"date":"2024-09-30","value":"0.41","vol":"0.37"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.42 | 0.30 | 0.13 | 0.57 | 0.41 |
| 行业(次) | 0.35 | 0.24 | 0.12 | 0.50 | 0.37 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.87","vol":"1.73"},{"date":"2025-06-30","value":"2.00","vol":"1.18"},{"date":"2025-03-31","value":"0.88","vol":"0.61"},{"date":"2024-12-31","value":"3.58","vol":"2.42"},{"date":"2024-09-30","value":"2.56","vol":"1.81"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.87 | 2.00 | 0.88 | 3.58 | 2.56 |
| 行业(次) | 1.73 | 1.18 | 0.61 | 2.42 | 1.81 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"0.54","vol":"9.48"},{"date":"2025-06-30","value":"19.98","vol":"20.05"},{"date":"2025-03-31","value":"12.56","vol":"-0.23"},{"date":"2024-12-31","value":"2.96","vol":"15.64"},{"date":"2024-09-30","value":"-10.92","vol":"5.86"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 0.54 | 19.98 | 12.56 | 2.96 | -10.92 |
| 行业 | 9.48 | 20.05 | -0.23 | 15.64 | 5.86 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.34","vol":"1.02"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.95","vol":"1.45"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.34 | - | 0.95 | - |
| 行业 | 0.00 | 1.02 | 0.00 | 1.45 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 55/109 ， 59/109。
[{"date":"2025-09-30","value":"4.44","vol":"3.05"},{"date":"2025-06-30","value":"4.11","vol":"2.90"},{"date":"2025-03-31","value":"4.43","vol":"2.99"},{"date":"2024-12-31","value":"3.99","vol":"2.88"},{"date":"2024-09-30","value":"4.86","vol":"3.25"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
4.44 | 4.11 | 4.43 | 3.99 | 4.86 |
| 行业 | 3.05 | 2.90 | 2.99 | 2.88 | 3.25 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"3.76","vol":"2.21"},{"date":"2025-06-30","value":"3.53","vol":"2.13"},{"date":"2025-03-31","value":"3.75","vol":"2.22"},{"date":"2024-12-31","value":"3.42","vol":"2.11"},{"date":"2024-09-30","value":"4.09","vol":"2.43"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
3.76 | 3.53 | 3.75 | 3.42 | 4.09 |
| 行业 | 2.21 | 2.13 | 2.22 | 2.11 | 2.43 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 29/109 ， 34/109。
[{"date":"2025-09-30","value":"27.60","vol":"33.12"},{"date":"2025-06-30","value":"28.57","vol":"33.87"},{"date":"2025-03-31","value":"28.05","vol":"33.29"},{"date":"2024-12-31","value":"29.70","vol":"34.05"},{"date":"2024-09-30","value":"28.18","vol":"32.87"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
27.60 | 28.57 | 28.05 | 29.70 | 28.18 |
| 行业(%) | 33.12 | 33.87 | 33.29 | 34.05 | 32.87 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.38","vol":"0.75"},{"date":"2025-06-30","value":"0.40","vol":"0.74"},{"date":"2025-03-31","value":"0.39","vol":"0.72"},{"date":"2024-12-31","value":"0.42","vol":"0.75"},{"date":"2024-09-30","value":"0.39","vol":"3.20"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.38 | 0.40 | 0.39 | 0.42 | 0.39 |
| 行业(%) | 0.75 | 0.74 | 0.72 | 0.75 | 3.20 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"1.02","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.68","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.86","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.37","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]